- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Total 315 results
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLocally Advanced or Metastatic Non-Small Cell Lung CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingMalignant Solid Tumors
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingAdvanced Solid Tumors
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingContrast-induced Acute Kidney InjuryChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingNewly Diagnosed Acute Myeloid Leukemia (AML)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPancreatic Cancer | Advanced Solid Tumor | Gastric Cancer (GC) | Gastroesophageal Junction (GEJ) CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Peritoneal Cancer
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingPeripheral T Cell LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingLymphoma | Cervical Cancer | Malignant Mesothelioma | Advanced Solid Tumours | Non-Small-Cell Lung CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedUnresectable or Metastatic Bone and Soft Tissue SarcomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Terminated
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedRelapsed or Refractory Acute Myeloid Leukemia (AML)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedAdvanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Active, not recruitingSARS-CoV-2 InfectionChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedHepatic ImpairmentChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Active, not recruitingAdvanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownFollicular LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownExtensive-Stage Small Cell Lung Cancer
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedDiabetic Neuropathy PeripheralChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownInvasive Aspergillosis | Invasive Candidiasis
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownNon-small Cell Lung Cancer
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.UnknownType2 Diabetes Mellitus
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Suspended
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Breast Cancer
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingLocally Advanced Unresectable Esophageal Squamous CarcinomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHead and Neck Cancer | Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingDiffuse Large B-Cell LymphomaChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Advanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAdvanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)China
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPancreatic CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAdvanced or Metastatic Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingAdvanced Solid TumorsChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingA Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic CancerAdvanced Pancreatic Cancer